- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01940380
The Study of LTBP1 of Postmenopausal Women Osteoporosis Molecular Mechanism of Kidney Yang Deficiency Syndrome
Postmenopausal Osteoporosis is characterized by a decrease in bone mass as well as a deterioration of the bone architecture resulting in an increased risk of fracture,which is directly related to the lack of estrogen and also associated with a variety of genetic and acquired factors. Previous studies have found that POP molecular regulation mechanism of kidney Yang deficiency syndrome may be associated with LTBP1 gene expression.
This topic using RT-PCR and Western Blot detection POP of kidney Yang deficiency group and healthy group LTBP1 mRNA and proteion's expression level,validate LTBP1 relevance to POP the kidney Yang deficiency syndrome.To provide a scientific basis for clinical treatment.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Fujian
-
Fu Zhou, Fujian, China, 350003
- Fujian Institute of Trational Chiness Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• The Participants who volunteer to be test subjects, and can accept experimental drugs, and promise to finish the course should sign the informed consent.
- Female ages 45 to 75 had gone through natural menopause before two years
- In accordance with the western medicine diagnostic criteria of osteoporosis and belong to kidney Yin deficiency syndrome differentiation of traditional Chinese medicine certificate;
- In accordance with the western medicine diagnostic criteria;
- In accordance with TCM diagnostic methods; .If any of the above answers are no, The subjects couldn't in the study
Exclusion Criteria:
Do not accord with standard of the western medicine diagnosis and TCM diagnostic methods
- Age: <44 and > 76 years old;
- With hyperparathyroidism, osteomalacia, rheumatoid arthritis, multiple myeloma and other serious complications such as secondary osteoporosis; Late or deformity, disability, loss of labor;
- With cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious primary diseases;
- Psychosis or alzheimer's patients;
- Nearly three months, the use of hormone replacement therapy (HRT) and taking calcitonin, nearly six months has used double phosphonic acid salt for 15 days, etc.;
- This medicine allergic constitution or composition of known to have allergies;
- In a critical condition, It's difficult to make exact evaluators to efficacy and safety of the new drugs;
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Postmenopausal Osteoporosis of kidney Yang deficiency syndrome
Time Frame: To observe the changes in gene expression(Day 1)
|
To observe the changes in gene expression(Day 1)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20130305
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Yang Deficiency Syndrome
-
Svijetlana Perculija DurdevicNanjing University of Chinese Medicine, Xueping Zhou, Li Ren; School of Medicine... and other collaboratorsCompletedKnee Osteoarthritis | Kidney Yin Deficiency | Kidney Yang DeficiencyCroatia
-
Beijing Hospital of Traditional Chinese MedicineNot yet recruitingFunctional Constipation
-
Hubei Hospital of Traditional Chinese MedicineUnknown
-
Galenic Research Institute LtdCompletedPeritoneal Neoplasms | Ascites | Yin Deficiency | Yang DeficiencyChina
-
Qiu-ping LinNot yet recruiting
-
Shanghai University of Traditional Chinese MedicineRecruiting
-
University of Colorado, DenverUniversity of Pittsburgh; National Institute of General Medical Sciences (NIGMS)CompletedChronic Kidney Diseases | Deficiency, Vitamin DUnited States
-
Peking University Third HospitalChina Academy of Chinese Medical Sciences; Beijing University of Chinese Medicine and other collaboratorsRecruitingYin Deficiency SyndromeChina
-
Pharmacosmos A/SCompletedChronic Kidney Disease | Iron Deficiency Anemia | Iron Deficiency AnaemiaUnited States
-
Vifor PharmaICON Clinical Research; American Regent, Inc.CompletedChronic Kidney Disease | Iron Deficiency AnaemiaUnited Kingdom, United States, Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Turkey